EHV-1 vectors
US6706515B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Inventors
Key dates
| Filing date | Mar 18, 2002 |
| Grant date | Mar 16, 2004 |
| Priority date | — |
| Expiry date | Mar 18, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16743
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to manipulation of equine herpes virus for use in gene therapy and in particular to modifications of the virus so that it can carry heterologous material and furthermore, preferably, be replication deficient so that the virus cannot replicate in the target tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.